Asherman's syndrome medical therapy: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-mgibson@perfuse.org +charlesmichaelgibson@gmail.com & -kfeeney@perfuse.org +kfeeney@elon.edu))
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Asherman's syndrome}}
{{Asherman's syndrome}}
'''Editor(s)-in-Chief:''' [[C. Michael Gibson]], M.S.,M.D. [mailto:charlesmichaelgibson@gmail.com] Phone:617-632-7753; [[User:Csinfor|Canan S Fornusek, Ph.D.]]; '''Associate Editor-In-Chief:''' {{MUT}}
'''Editor(s)-in-Chief:''' {{CMG}}; [[User:Csinfor|Canan S Fornusek, Ph.D.]]; '''Associate Editor-In-Chief:''' {{skhan}}
==Overview==
==Overview==
Medical therapy usually follows surgical removal of fibrous bands in the uterus causing the condition. Estrogen provides stimulation for endometrial proliferation.
==Medical Therapy==
==Medical Therapy==
Hormonal therapy with synthetic or conjugated [[estrogen]] is usually prescribed following surgery to stimulate endometrial growth thereby preventing the walls of the uterus from re-adhering.
Hormonal therapy with synthetic or conjugated [[estrogen]] is usually prescribed following surgery to stimulate endometrial growth thereby preventing the walls of the uterus from re-adhering.
Line 10: Line 11:
{{Reflist|2}}
{{Reflist|2}}


[[Category:Needs content]]
 


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Revision as of 20:10, 6 July 2022

Asherman's syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Asherman's syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Asherman's syndrome medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Asherman's syndrome medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Asherman's syndrome medical therapy

CDC on Asherman's syndrome medical therapy

Asherman's syndrome medical therapy in the news

Blogs on Asherman's syndrome medical therapy

Directions to Hospitals Treating Asherman's syndrome

Risk calculators and risk factors for Asherman's syndrome medical therapy

Editor(s)-in-Chief: Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Canan S Fornusek, Ph.D.; Associate Editor-In-Chief: Saud Khan M.D.

Overview

Medical therapy usually follows surgical removal of fibrous bands in the uterus causing the condition. Estrogen provides stimulation for endometrial proliferation.

Medical Therapy

Hormonal therapy with synthetic or conjugated estrogen is usually prescribed following surgery to stimulate endometrial growth thereby preventing the walls of the uterus from re-adhering.

More studies are needed to evaluate which method of treatment is most likely to have a successful outcome.

References



Template:WikiDoc Sources